DK1267922T3 - Polysaccharidkonjugater af pneumokokker til anvendelse som vaccine mod tetanus og difteri - Google Patents

Polysaccharidkonjugater af pneumokokker til anvendelse som vaccine mod tetanus og difteri

Info

Publication number
DK1267922T3
DK1267922T3 DK01917183T DK01917183T DK1267922T3 DK 1267922 T3 DK1267922 T3 DK 1267922T3 DK 01917183 T DK01917183 T DK 01917183T DK 01917183 T DK01917183 T DK 01917183T DK 1267922 T3 DK1267922 T3 DK 1267922T3
Authority
DK
Denmark
Prior art keywords
diphtheria
pneumococci
vaccine against
polysaccharide conjugates
against tetanus
Prior art date
Application number
DK01917183T
Other languages
English (en)
Inventor
Dominique Schulz
Original Assignee
Sanofi Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8848189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1267922(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Pasteur filed Critical Sanofi Pasteur
Application granted granted Critical
Publication of DK1267922T3 publication Critical patent/DK1267922T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
DK01917183T 2000-03-17 2001-03-19 Polysaccharidkonjugater af pneumokokker til anvendelse som vaccine mod tetanus og difteri DK1267922T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0003407A FR2806304B1 (fr) 2000-03-17 2000-03-17 Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie
PCT/FR2001/000820 WO2001068128A1 (fr) 2000-03-17 2001-03-19 Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie

Publications (1)

Publication Number Publication Date
DK1267922T3 true DK1267922T3 (da) 2005-10-17

Family

ID=8848189

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01917183T DK1267922T3 (da) 2000-03-17 2001-03-19 Polysaccharidkonjugater af pneumokokker til anvendelse som vaccine mod tetanus og difteri

Country Status (11)

Country Link
US (1) US20030099672A1 (da)
EP (1) EP1267922B1 (da)
AT (1) ATE297758T1 (da)
AU (1) AU2001244275A1 (da)
CA (1) CA2402807A1 (da)
DE (1) DE60111507T2 (da)
DK (1) DK1267922T3 (da)
ES (1) ES2240432T3 (da)
FR (1) FR2806304B1 (da)
PT (1) PT1267922E (da)
WO (1) WO2001068128A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA011480B1 (ru) * 2000-06-29 2009-04-28 Глаксосмитклайн Байолоджикалс С.А. Поливалентная вакцинная композиция
EP3009146B1 (en) 2005-06-27 2021-10-20 Pfizer Ireland Pharmaceuticals Immunogenic composition
GB0607088D0 (en) * 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
CA2633772C (en) * 2005-12-22 2015-09-15 Ralph Leon Biemans Pneumococcal polysaccharide conjugate vaccine
PL2167121T3 (pl) 2007-06-26 2016-01-29 Glaxosmithkline Biologicals Sa Szczepionka zawierająca koniugaty polisacharydu otoczkowego streptococcus pneumoniae
GB2495341B (en) * 2011-11-11 2013-09-18 Novartis Ag Fermentation methods and their products
KR102057217B1 (ko) 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
ITMI20121597A1 (it) 2012-09-25 2014-03-26 Beta Pharma S A Coniugato tra frammento di parete cellulare batterica ed un veicolo mucopolisaccaridico e suoi usi in ambito medico
KR20140075196A (ko) 2012-12-11 2014-06-19 에스케이케미칼주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
CN105007935A (zh) * 2012-12-18 2015-10-28 葛兰素史密丝克莱恩生物有限公司 用于保护免于白喉和/或破伤风的缀合物
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
CA3031797A1 (en) * 2016-08-05 2018-02-08 Sanofi Pasteur, Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
EP3493837B1 (en) 2016-08-05 2022-08-31 Sanofi Pasteur, Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
MX2019014829A (es) 2017-06-10 2020-08-17 Inventprise Llc Vacunas de conjugado multivalente con polisacáridos de conjugado bivalente o multivalente que proporcionan inmunogenicidad y avidez mejoradas.
BR112020014978A2 (pt) 2018-02-05 2020-12-22 Sanofi Pasteur, Inc. Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
WO2019152925A1 (en) * 2018-02-05 2019-08-08 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
TW202011985A (zh) 2018-04-18 2020-04-01 韓商Ｓｋ生物科學股份有限公司 肺炎鏈球菌的莢膜多醣類以及其免疫原性接合體
CN113607939A (zh) * 2021-08-05 2021-11-05 艾美探索者生命科学研发有限公司 肺炎球菌多糖结合疫苗各型结合原液吸附率测定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619828A (en) * 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
US5204098A (en) * 1988-02-16 1993-04-20 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-protein conjugates
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
FR2682388B1 (fr) * 1991-10-10 1995-06-09 Pasteur Merieux Serums Vacc Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
JP4233113B2 (ja) * 1995-06-07 2009-03-04 グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム 多糖類抗原−キャリア蛋白接合体および遊離キャリア蛋白を有してなるワクチン
FR2763244B1 (fr) * 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
US6284250B1 (en) * 1998-02-05 2001-09-04 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media

Also Published As

Publication number Publication date
ATE297758T1 (de) 2005-07-15
US20030099672A1 (en) 2003-05-29
AU2001244275A1 (en) 2001-09-24
WO2001068128A1 (fr) 2001-09-20
FR2806304B1 (fr) 2002-05-10
DE60111507T2 (de) 2006-05-11
FR2806304A1 (fr) 2001-09-21
DE60111507D1 (de) 2005-07-21
EP1267922B1 (fr) 2005-06-15
CA2402807A1 (en) 2001-09-20
EP1267922A1 (fr) 2003-01-02
PT1267922E (pt) 2005-09-30
ES2240432T3 (es) 2005-10-16

Similar Documents

Publication Publication Date Title
DK1267922T3 (da) Polysaccharidkonjugater af pneumokokker til anvendelse som vaccine mod tetanus og difteri
RS54349B1 (en) VACCINE CONTAINING STREPTOCOCCUS PNEUMONIAE Capsular POLYSACCHARIDE CONJUGATES
NZ595178A (en) Vaccine comprising Type 5 and Type 8 capsular polysaccharides from Staphyloccocus aureus
MY150719A (en) Pneumococcal polysaccharide conjugate vaccine
HUP0301413A1 (hu) Vakcinakészítmények
MY125387A (en) Vaccine
HRP20160685T1 (hr) Pripravci koji sadrže pneumokokne antigene
PE20161095A1 (es) Composiciones inmunogenicas que comprenden antigenos de sacaridos capsulares conjugados y uso de los mismos
CY1110140T1 (el) Εμβολιασμος με μηνιγγοκοκκικο συζευγμα
WO2002091998A3 (en) Novel meningitis conjugate vaccine
EA200801935A1 (ru) Конъюгатные вакцины
UA99703C2 (en) Use of streptococcus pneumoniae immunogenic composition
CO5241278A1 (es) Vacuna